Alliance Foundation Trials Phase III PATINA Study Results Published in the New England Journal of Medicine

Evanthia Galanis, MD, DSc | President

Evanthia Galanis, MD, DSc, is President of Alliance Foundation Trials (AFT) LLC and Group Chair of the Alliance for Clinical Trials in Oncology, where she provides scientific and strategic leadership for one of the nation’s largest oncology clinical trials networks. She is the Sandra J. Schulze Professor of Novel Therapeutics and Professor of Oncology at Mayo Clinic, with joint appointments in the Division of Medical Oncology and the Department of Molecular Medicine.

An internationally recognized leader in neuro-oncology, Dr. Galanis has led numerous cooperative group phase II and randomized clinical trials and maintains a strong research focus on innovative trial design and clinically meaningful endpoints in neuro-oncology.

Olwen Hahn, MD | Vice President

Olwen Hahn, MD, serves as Vice President of Alliance Foundation Trials (AFT) LLC and contributes clinical and operational leadership to advance high-quality oncology research. She is an Associate Professor of Medicine at the University of Chicago and serves as Director and Principal Investigator of the Alliance Central Protocol Operations Program, where she oversees the clinical operations of a large national portfolio of oncology studies.

A nationally recognized breast cancer specialist, Dr. Hahn’s clinical practice focuses on the diagnosis and treatment of all forms of breast cancer, integrating standard therapies with innovative clinical trials to deliver personalized patient care.

Kimberly Kerstann, PhD – Secretary

Kimberly Kerstann, PhD, serves as Secretary of Alliance Foundation Trials (AFT) LLC and is Chief Operating Officer of the Alliance for Clinical Trials in Oncology. She brings extensive experience in scientific research, clinical trials administration, and organizational leadership, supporting AFT’s mission through strong governance, operational excellence, and regulatory oversight.

Dr. Kerstann is committed to aligning scientific innovation with effective operational strategy to strengthen research infrastructure and support the successful execution of complex, multi-institutional clinical trials.

Drew Gollerkeri, MBA | Treasurer

Drew Gollerkeri, MBA, serves as Treasurer of Alliance Foundation Trials (AFT) LLC, providing financial leadership and strategic oversight in support of the organization’s clinical research mission. He brings experience in financial management, operational strategy, and organizational governance within complex healthcare and research environments.

In his role, Mr. Gollerkeri oversees budgeting, financial planning, and fiscal stewardship to ensure responsible resource allocation, long-term sustainability, and alignment with AFT’s scientific and operational priorities.

David Kozono, MD, PhD | Group Vice Chair and Principal Investigator

David Kozono, MD, PhD, serves as Group Vice Chair and Principal Investigator of the Alliance for Clinical Trials in Oncology and supports the overall advancement of Alliance Foundation Trials (AFT) LLC and its mission to develop and execute practice-changing oncology studies. He is an Associate Professor of Radiation Oncology at Harvard Medical School and Director of Thoracic Radiation Oncology at the Dana-Farber/Brigham and Women’s Cancer Center.

Dr. Kozono specializes in the treatment of thoracic malignancies, including lung cancer, and is committed to translating scientific discoveries into the design and conduct of innovative clinical trials with strong translational medicine objectives. His work reflects a dedication to integrating rigorous science with clinical care to improve outcomes for patients with cancer. 

Executive Officers

• Lyudmila Bazhenova, MD | University of California San Diego

• Stephanie Berg, DO | Dana-Farber Cancer Institute
  
   

• Selina Chow, MD | Alliance for Clinical Trials in Oncology
   

• Shira Dinner, MD | Northwestern University
   

• Beth Helmink, MD, PhD | University of Texas MD Anderson Cancer Center

• Priya Kumthekar, MD | Northwestern University
  
   

• Filipa Lynce, MD | Dana-Farber Cancer Institute
   

• Otto Metzger, MD | Dana-Farber Cancer Institute
   

• Ardaman Shergill, MD | University of Chicago

• Gloria Sura, MD | University of Texas MD Anderson Cancer Center

• Anna Weiss, MD | University of Rochester Medical Center